EUVIMEDEUVIMED entdecken
Metaanalyse

Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials

Babak Ghadirzadeh, Maziar Afshar, Yousef Moradi

Current Pharmacology Reports · 26.03.2026 · 12 (1)

DOI: 10.1007/s40495-026-00451-4 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Current Pharmacology Reports, online erschienen am 26.03.2026. Verfasst von Babak Ghadirzadeh und 2 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ghadirzadeh, B., Afshar, M., & Moradi, Y. (2026). Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials. Current Pharmacology Reports, 12(1). https://doi.org/10.1007/s40495-026-00451-4

Vancouver

Ghadirzadeh B, Afshar M, Moradi Y. Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials. Current Pharmacology Reports. 2026;12(1). doi:10.1007/s40495-026-00451-4

BibTeX
@article{Ghadirzadeh2026,
  author = {Ghadirzadeh, Babak and Afshar, Maziar and Moradi, Yousef},
  title = {Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials},
  journal = {Current Pharmacology Reports},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1007/s40495-026-00451-4}
}
Kostenlos starten →